Výsledky vyhledávání - "Julie Rivers"

Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence

Autor: Karen, MacKinnon, Lenora, Marcellus, Julie, Rivers, Carol, Gordon, Maureen, Ryan, Diane, Butcher

Publikováno v: JBI Database of Systematic Reviews and Implementation Reports. 15:2666-2706

Although maternal-child care is a pillar of primary health care, there is a global shortage of maternal-child health care providers. Nurse educators experience difficulties providing undergraduate students with maternal-child learning experiences for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc86781f2ea276848423bfb1621b5fa1
https://doi.org/10.11124/jbisrir-2016-003147

Zobrazit plný text záznamu

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Autor: Hannah Brakke, Olivia Finney, Kasey J. Leger, Juliane Gust, Todd M. Cooper, Rebecca Gardner, Daniel H. Li, Julie Rivers, Corinne Summers, Julie R. Park, Francesco Ceppi, Michael C. Jensen, Agne Taraseviciute, Colleen Annesley, Katherine Tarlock

Publikováno v: Blood. 134(24)

Immunotherapy with the adoptive transfer of T cells redirected with CD19-specific chimeric antigen receptors (CARs) for B-lineage acute lymphoblastic leukemia (ALL) can salvage >80% of patients having relapsed/refractory disease. The therapeutic inde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776789e66ab4eca76a24f64c91383ddf
https://pubmed.ncbi.nlm.nih.gov/31830277

Zobrazit plný text záznamu

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma

Autor: Catherine Lindgren, Navin Pinto, Francesco Ceppi, Julie Rivers, Naomi Linn, Meghan Delaney, Colleen Annesley, Stephanie Mgebroff, Rebecca Gardner, Julie R. Park

Publikováno v: Transfusion. 58(6)

Background The first step in the production of chimeric antigen receptor T cells is the collection of autologous T cells using apheresis technology. The procedure is technically challenging, because patients often have low leukocyte counts and are he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ccd3e718d58c67eb067237a166188e
https://pubmed.ncbi.nlm.nih.gov/29949188

Zobrazit plný text záznamu

Campus Clinical

Autor: Michelle Jarvis, Julie Rivers

Publikováno v: Nurse Educator. 39:179-183

Campus Clinical is a simulation-based curriculum designed to meet the challenge of decreasing clinical spaces in maternal-child units. The curriculum framework is situated in a constructivist, experiential learning context, integrating Chickering and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29c78b767f75b9bb6c3c4b47ce2bb3c
https://doi.org/10.1097/nne.0000000000000045

Zobrazit plný text záznamu

Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo

Autor: Christopher Brown, Adam Brand, Qian Vicky Wu, Karen Spratt, Michael C. Jensen, Stephanie Mgebroff, Adam J. Lamble, Adam Johnson, Rebecca Gardner, Julie R. Park, Corinne Summers, Catherine Lindgren, Julie Rivers, Ashley Wilson, Colleen Annesley

Publikováno v: Blood. 134:223-223

Background: While immunotherapy withCD19 specific CAR T cells for relapsed/refractory (R/R) B-ALL achieves MRD negative remission in nearly all patients, relapse occurs in approximately half of patients and is frequently associated with early loss of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63973320fdfd8ca50c7624dac42afafb
https://doi.org/10.1182/blood-2019-131346

Zobrazit plný text záznamu

Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses

Autor: Adam J. Lamble, Adam Brand, Alan S. Wayne, Ashley Wilson, Christopher Brown, Julie Rivers, Qian Vicky Wu, Michael C. Jensen, Michael A. Pulsipher, Colleen Annesley, Corinne Summers, Stephanie Mgebroff, Rebecca Gardner, Julie R. Park, Catherine Lindgren

Publikováno v: Blood. 134:3869-3869

Background: The youngest patients referred for CAR T cell therapy are those with relapsed or refractory (R/R) KMT2A-rearranged infant B-ALL. Infants with relapsed ALL following Interfant-99 therapy have a dismal reported 3-yr OS of 20.9%, indicating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7617829e38401c087d66ceb4cafee218
https://doi.org/10.1182/blood-2019-131447

Zobrazit plný text záznamu

Distribution and Abundance Estimates for Cetaceans in the Waters off Guam and the Commonwealth of the Northern Mariana Islands

Autor: Julie Rivers, Philip H. Thorson, Gregory L. Fulling

Publikováno v: Pacific Science. 65:321-343

Cetacean distribution and abundance are reported from the first systematic line-transect visual survey in the waters of Guam and the Commonwealth of the Northern Mariana Islands (CNMI). The survey was conducted during January–April 2007 following s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::666a22658baf3d1da78bc9ed512e0ec0
https://doi.org/10.2984/65.3.321

Zobrazit plný text záznamu

Early Response Data for Pediatric Patients with Non-Hodgkin Lymphoma Treated with CD19 Chimeric Antigen Receptor (CAR) T-Cells

Autor: Alan S. Wayne, Olivia Finney, Corinne Summers, Julie Rivers, Michael C. Jensen, Colleen Annesley, Rebecca Gardner, Julie R. Park, Michael A. Pulsipher

Publikováno v: Blood. 132:2957-2957

Background:Pediatric patients with relapsed or refractory CD19+non-Hodgkin lymphoma (NHL) have poor outcomes despite use of chemotherapy and hematopoietic stem cell transplant (HSCT). Clinical trials of CD19 CAR T-cells have demonstrated efficacy in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e654943495d0f7123a030706cc11f7a0
https://doi.org/10.1182/blood-2018-99-113744

Zobrazit plný text záznamu

Novel CD19t T-Antigen Presenting Cells Designed to Re-Activate and Expand CD19 CAR T Cells In Vivo: Early Demonstration of Feasibility and Safety

Autor: Adam Johnson, Karen Spratt, Olivia Finney, Christopher Brown, Julie Rivers, Colleen Annesley, Corinne Summers, Stephanie Mgebroff, Catherine Lindgren, Rebecca Gardner, Julie R. Park, Adam J. Lamble, Michael C. Jensen

Publikováno v: Blood. 132:4021-4021

Background: Immunotherapy with CD19 specific chimeric antigen receptor (CAR) T cells for relapsed/refractory acute lymphoblastic leukemia (ALL) demonstrated a minimal residual disease (MRD) negative remission rate of 93% on the phase 1 portion of Ped

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e0acd83358a37e341a6caf4d1b2dfbc2
https://doi.org/10.1182/blood-2018-99-112285

Zobrazit plný text záznamu

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

Autor: Kaelin Crews, Adam Johnson, Stephanie Mgebroff, Adam J. Lamble, Karen Spratt, Corinne Summers, Rebecca Gardner, Catherine Lindgren, Julie R. Park, Christopher Brown, Olivia Finney, Michael C. Jensen, Colleen Annesley, Josh Gustafson, Lauren Huang, Julie Rivers

Publikováno v: Blood. 132:278-278

Introduction: Advances in chimeric antigen receptor (CAR) T cell therapy have yielded complete remission (CR) rates in relapsed/refractory B-ALL (rrB-ALL) of 70-95%. However, disease recurrence after CD19 or CD22 CAR therapy is greater than 50% at 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::be30a5cbc44b080796859402e7cc1000
https://doi.org/10.1182/blood-2018-99-113126

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání